{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:32:07Z","timestamp":1787772727158,"version":"build-2784847793"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>CD47 is a membrane protein that belongs to the immunoglobulin superfamily and regulates macrophage phagocytosis negatively. As CD47 expression at the cancer cell membrane would inhibit the phagocytic activity of immune cells, it is connected to an unfavorable prognosis in leukemia and malignancies of various solid organs. Materials and<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this study, retrospectively evaluated 72 patients who had been diagnosed with endometrial carcinoma at Pathology Department and had undergone total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH + BSO) and\/or lymphadenectomy. CD47 expression was evaluated in tumorous and nontumor areas in all patients considering cytoplasmic and membranous brown staining in cells. The proportion of expression was evaluated as well as the intensity and an \u201ch score\u201d was obtained. This score was compared with known prognostic parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      CD47 expressions showed a statistically significant correlation with tumor grade (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05); however, no significant relationship was observed with myometrial invasion depth and lymph vascular invasion status (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.923 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.754, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>As with other tumors, anti-CD47 antibody may be an alternative treatment option in patients with high-grade endometrial carcinoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijpm.ijpm_223_21","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T15:34:53Z","timestamp":1724945693000},"page":"856-859","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Significance of CD47 expression in endometrial carcinoma"],"prefix":"10.4103","volume":"65","author":[{"given":"Nurhan","family":"Sahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganime","family":"Coban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurcan","family":"Unver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek S.","family":"Arici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Toluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20240829","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.tranon.2017.07.007","article-title":"Isolation of stem-like cancer cells in primary endometrial cancer using cell surface markers CD133 and CXCR4","volume":"10","author":"Sun","year":"2017","journal-title":"Transl Oncol"},{"key":"R2-20-20240829","doi-asserted-by":"crossref","first-page":"6156757","DOI":"10.1155\/2018\/6156757","article-title":"CD47 blockade inhibits tumour progression through promoting phagocytosis of tumour cells by M2 polarized macrophages in endometrial cancer","volume":"2018","author":"Gu","year":"2018","journal-title":"J Immunol Res"},{"key":"R3-20-20240829","doi-asserted-by":"crossref","first-page":"39021","DOI":"10.18632\/oncotarget.16547","article-title":"CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"R4-20-20240829","doi-asserted-by":"crossref","first-page":"83040","DOI":"10.18632\/oncotarget.13349","article-title":"A fully human anti-CD47 blocking antibody with therapeutic potential for cancer","volume":"7","author":"Zeng","year":"2016","journal-title":"Oncotarget"},{"key":"R5-20-20240829","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukaemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell"},{"key":"R6-20-20240829","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/cam4.478","article-title":"CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer","volume":"4","author":"Yoshida","year":"2015","journal-title":"Cancer Med"},{"key":"R7-20-20240829","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1158\/0008-5472.CAN-10-2238","article-title":"Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukaemia","volume":"71","author":"Chao","year":"2011","journal-title":"Cancer Res"},{"key":"R8-20-20240829","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1038\/leu.2012.141","article-title":"Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells","volume":"26","author":"Kim","year":"2012","journal-title":"Leukaemia"},{"key":"R9-20-20240829","doi-asserted-by":"crossref","first-page":"103014","DOI":"10.1016\/j.critrevonc.2020.103014","article-title":"CD47: The next checkpoint target for cancer immunotherapy","volume":"152","author":"Ridong","year":"2020","journal-title":"Crit Rev Oncol Haematol"},{"key":"R10-20-20240829","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13045-016-0381-z","article-title":"Is CD47 an innate immune checkpoint for tumour evasion?","volume":"10","author":"Liu","year":"2017","journal-title":"J Hematol Oncol"},{"key":"R12-20-20240829","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00000478-200009000-00002","article-title":"A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advanced-stage tumours with favourable and unfavourable prognosis","volume":"24","author":"Lax","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R13-20-20240829","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.coi.2012.01.010","article-title":"The CD47\u2013SIRP\u03b1 pathway in cancer immune evasion and potential therapeutic implications","volume":"24","author":"Chao","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"R14-20-20240829","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00384-012-1541-4","article-title":"Association study identifying polymorphisms in CD47 and other extracellular matrix pathway genes as putative prognostic markers for colorectal cancer","volume":"28","author":"Lascorz","year":"2013","journal-title":"Int J Colorectal Dis"},{"key":"R16-20-20240829","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","article-title":"CD47 is up regulated on circulating hematopoietic stem cells and leukaemia cells to avoid phagocytosis","volume":"138","author":"Jaiswal","year":"2009","journal-title":"Cell"},{"key":"R17-20-20240829","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1073\/pnas.1121629109","article-title":"Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma","volume":"109","author":"Edris","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-20-20240829","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/cam4.2882","article-title":"Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer","volume":"9","author":"Arrieta","year":"2020","journal-title":"Cancer Med"},{"key":"R19-20-20240829","first-page":"9075","article-title":"CD47 as a potential prognostic marker for oral leukoplakia and oral squamous cell carcinoma","volume":"15","author":"Ye","year":"2018","journal-title":"Oncol Lett"},{"key":"R20-20-20240829","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3892\/ol.2017.6257","article-title":"Significance of CD47 expression in gastric cancer","volume":"14","author":"Sudo","year":"2017","journal-title":"Oncol Lett"},{"key":"R21-20-20240829","first-page":"349","article-title":"Relationship between immunohistochemical staining extent of CD47 and histopathologic features of bladder tumour","volume":"70","author":"Olcucuoglu","year":"2017","journal-title":"Cent European J Urol"},{"key":"R22-20-20240829","first-page":"2901","article-title":"Overexpression of CD47 predicts poor prognosis and promotes cancer cell invasion in high-grade serous ovarian carcinoma","volume":"9","author":"Li","year":"2017","journal-title":"Am J Transl Res"},{"key":"R23-20-20240829","doi-asserted-by":"crossref","first-page":"e1373235","DOI":"10.1080\/2162402X.2017.1373235","article-title":"The \u201cdon't eat me\u201d signal CD47 is a novel diagnostic biomarker and potential therapeutic target for diffuse malignant mesothelioma","volume":"7","author":"Sch\u00fcrch","year":"2018","journal-title":"Oncoimmunology"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpm.ijpm_223_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:10:39Z","timestamp":1787771439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpm.ijpm_223_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijpm.ijpm_223_21","relation":{},"ISSN":["0377-4929"],"issn-type":[{"value":"0377-4929","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}